Elevance Health will buy private firm Paragon Healthcare for more than $1 billion, according to three people familiar with the matter, Axios reported.
The health insurer had said earlier on Thursday it would acquire Paragon Healthcare, but did not disclose the financials of the deal.
After the acquisition, Paragon, which provides drug infusion services to patients at home and at its centres, will operate as part of CarelonRx, the pharmacy services segment within Elevance’s health services division, Carelon.
The acquisition is expected to close in the first half of 2024 and is not likely to have a material impact on Elevance’s 2024 adjusted profit, the insurer said.
Elevance declined a Reuters request to comment on the financial details of the deal.
Source: Reuters.com